Glucose Health Stock Net Income
| GLUC Stock | USD 0.20 0.02 9.09% |
As of the 13th of February 2026, Glucose Health retains the Market Risk Adjusted Performance of (5.66), risk adjusted performance of 0.1063, and Downside Deviation of 11.48. Glucose Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Glucose Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Glucose Health's valuation are provided below:Glucose Health does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Glucose |
Glucose Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Glucose Health's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Glucose Health.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Glucose Health on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Glucose Health or generate 0.0% return on investment in Glucose Health over 90 days. Glucose Health is related to or competes with High Liner, Morningstar Unconstrained, High-yield Municipal, Thrivent High, Via Renewables, T Rowe, and Bondbloxx ETF. Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nut... More
Glucose Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Glucose Health's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Glucose Health upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 11.48 | |||
| Information Ratio | 0.113 | |||
| Maximum Drawdown | 95.26 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 20.0 |
Glucose Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Glucose Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Glucose Health's standard deviation. In reality, there are many statistical measures that can use Glucose Health historical prices to predict the future Glucose Health's volatility.| Risk Adjusted Performance | 0.1063 | |||
| Jensen Alpha | 1.52 | |||
| Total Risk Alpha | 0.3992 | |||
| Sortino Ratio | 0.1248 | |||
| Treynor Ratio | (5.67) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Glucose Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Glucose Health February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1063 | |||
| Market Risk Adjusted Performance | (5.66) | |||
| Mean Deviation | 8.33 | |||
| Semi Deviation | 8.42 | |||
| Downside Deviation | 11.48 | |||
| Coefficient Of Variation | 837.67 | |||
| Standard Deviation | 12.68 | |||
| Variance | 160.79 | |||
| Information Ratio | 0.113 | |||
| Jensen Alpha | 1.52 | |||
| Total Risk Alpha | 0.3992 | |||
| Sortino Ratio | 0.1248 | |||
| Treynor Ratio | (5.67) | |||
| Maximum Drawdown | 95.26 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 20.0 | |||
| Downside Variance | 131.79 | |||
| Semi Variance | 70.93 | |||
| Expected Short fall | (12.51) | |||
| Skewness | 1.8 | |||
| Kurtosis | 9.01 |
Glucose Health Backtested Returns
Glucose Health is out of control given 3 months investment horizon. Glucose Health holds Efficiency (Sharpe) Ratio of 0.0935, which attests that the entity had a 0.0935 % return per unit of risk over the last 3 months. We are able to break down and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.2% are justified by taking the suggested risk. Use Glucose Health Downside Deviation of 11.48, market risk adjusted performance of (5.66), and Risk Adjusted Performance of 0.1063 to evaluate company specific risk that cannot be diversified away. Glucose Health holds a performance score of 7 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.27, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Glucose Health are expected to decrease at a much lower rate. During the bear market, Glucose Health is likely to outperform the market. Use Glucose Health value at risk and the relationship between the expected short fall and price action indicator , to analyze future returns on Glucose Health.
Auto-correlation | -0.34 |
Poor reverse predictability
Glucose Health has poor reverse predictability. Overlapping area represents the amount of predictability between Glucose Health time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Glucose Health price movement. The serial correlation of -0.34 indicates that nearly 34.0% of current Glucose Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.34 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Glucose Health reported net income of (338,904). This is 100.03% lower than that of the Consumer Defensive sector and 99.65% lower than that of the Packaged Foods industry. The net income for all United States stocks is 100.06% higher than that of the company.
Glucose Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Glucose Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Glucose Health could also be used in its relative valuation, which is a method of valuing Glucose Health by comparing valuation metrics of similar companies.Glucose Health is currently under evaluation in net income category among its peers.
Glucose Fundamentals
| Return On Equity | -0.5 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (0.32) % | |||
| Operating Margin | (0.32) % | |||
| Current Valuation | 1.16 M | |||
| Shares Outstanding | 4.55 M | |||
| Shares Owned By Insiders | 10.14 % | |||
| Shares Owned By Institutions | 0.25 % | |||
| Price To Earning | (1.99) X | |||
| Price To Sales | 3.42 X | |||
| Revenue | 1.11 M | |||
| Gross Profit | (2.41 K) | |||
| EBITDA | (336.06 K) | |||
| Net Income | (338.9 K) | |||
| Cash And Equivalents | 569.39 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 332.88 K | |||
| Current Ratio | 545.85 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (72.74 K) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 3.12 | |||
| Market Capitalization | 2.68 M | |||
| Total Asset | 207 K | |||
| Retained Earnings | (5.96 M) | |||
| Working Capital | (217 K) | |||
| Current Asset | 207 K | |||
| Current Liabilities | 424 K | |||
| Z Score | -33.9 |
About Glucose Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Glucose Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glucose Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glucose Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Glucose Pink Sheet
Glucose Health financial ratios help investors to determine whether Glucose Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Glucose with respect to the benefits of owning Glucose Health security.